According to Dr. Bertha Madras, deputy director of demand reduction in the White House Office of National Drug Control Policy under President George W. Bush, random drug testing gives young people a good reason not to succumb to peer pressure. But the implementation of random drug testing in schools has stirred a controversial public health debate. Is this an invasion of privacy? Is school an appropriate environment for these measures? Dr. Madras provides a detailed explanation of current policy, and responds to critical comments from groups that oppose the widespread implementation of random drug testing in schools. Dr. Bill Rutenberg hosts.
Random Drug Testing in Schools
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
According to Dr. Bertha Madras, deputy director of demand reduction in the White House Office of National Drug Control Policy under President George W. Bush, random drug testing gives young people a good reason not to succumb to peer pressure. But the implementation of random drug testing in schools has stirred a controversial public health debate. Is this an invasion of privacy? Is school an appropriate environment for these measures? Dr. Madras provides a detailed explanation of current policy, and responds to critical comments from groups that oppose the widespread implementation of random drug testing in schools. Dr. Bill Rutenberg hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Cardiology
Phase 3 study results of plozasiran in patients with FCS
<p>Phase 3 study results of plozasiran in patients with FCS</p>
CME/CE
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
0.25 credits
<p>Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective</p>
CME/CE
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
0.50 credits
<p>IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement</p>
CME/CE
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
0.25 credits
<p>IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy</p>
CME/CE Broadcast Replay
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
1.00 credits
<p>Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference</p>
MinuteCE®
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
1.00 credits
<p>Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time</p>
MinuteCE®
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
1.00 credits
<p>Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D</p>
CME/CE
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
<p>FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?